VAERS reports by lot

GSK Hepatitis B lot P2443: VAERS reports

45 VAERS reports list lot P2443 as a GSK Hepatitis B vaccine, received between 2025-04-23 and 2026-03-30. Data: VAERS public files through 28 May 2026 (site extract 2026-10-28).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
45
Reports
4%
Marked serious
0
With a death outcome
10
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological1418%
General / Systemic (non-local)1215%
Injection-site / Local reaction1215%
Musculoskeletal911%
Cardiac / Cardiovascular810%
Gastrointestinal810%
Allergic / Anaphylactic79%
Dermatological (non-injection-site)79%
Psychiatric / Neuropsychiatric22%
Autoimmune / Immune-mediated11%

Where reports came from

U.S. state of the reporter, where given (top 12).

StateReports
Florida6
Minnesota6
Texas5
Alabama4
Virginia3
California2
Indiana2
Massachusetts2
Illinois1
North Carolina1
Oklahoma1
Michigan1

Reports by month received

MonthReportsBar
2025-043
2025-053
2025-067
2025-079
2025-087
2025-095
2025-102
2025-116
2025-121
2026-032

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Nearby GSK Hepatitis B lots (A–Z): H7RF2 · J477Y · M4B34 · X239D

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-10-28 18:08 UTC. Not medical advice. Report errors via contact.